Related Experiment Video
Updated: Jun 28, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Addiction in chronic inflammatory skin diseases: A systematic review of prevalence, impact and screening practices
Enya Müller1, Stefanie Ziehfreund1, Magdalena Saak1
1School of Medicine and Health, Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Background:
Chronic inflammatory skin diseases are frequently associated with addictive behaviours, which may affect disease course, mental health and treatment outcomes. Yet, existing data remain fragmented across addiction types and dermatologic conditions.
Objectives:
To systematically review the prevalence of substance-related and behavioural addictions in adults with selected skin diseases and to evaluate the methodological quality of the available evidence.
Methods:
A systematic search of PubMed and Embase was conducted through April 2025. Eligible studies included observational designs investigating adult populations with alopecia areata, atopic dermatitis, hidradenitis suppurativa, psoriasis, urticaria or vitiligo and reporting outcomes related to alcohol, nicotine substance use or behavioural addictions (e.g. internet or gambling). Methodological quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS).
Results:
Thirty-eight studies were included and psoriasis, atopic dermatitis and hidradenitis suppurativa were the most frequently investigated diseases. Alcohol addiction (prevalence up to 50%) and nicotine abuse (up to 40%) were the most common addictions, followed by substance use disorder and behavioural addictions (e.g. internet addiction up to 38%). Addictions were associated with greater disease severity, reduced treatment response and higher comorbidity burden. Two-thirds of studies met > 90% of STROBE criteria, but heterogeneity in design, assessment tools and reporting limited comparability.
Conclusions:
Addictive behaviours are common among patients with chronic skin diseases and may influence clinical outcomes. Systematic screening, particularly for underrecognized behavioural addictions, and age- and sex-stratified care approaches, should be integrated into dermatological practice.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Inflammation: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations